Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA project: An ecological study of 18 populations

Stroke

Volumn 28, Issue 7, 1997, Pages 1367-1374

  Stegmayr, Birgitta ^a   Asplund, Kjell ^a   Kuulasmaa, Kari ^b   Rajakangas, Anna Maija ^b   Thorvaldsen, Per ^c   Tuomilehto, Jaakko ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cerebrovascular disorders; Epidemiology; Hypertension; Risk factors

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHINA; DENMARK; FEMALE; FINLAND; HUMAN; HYPERTENSION; INCIDENCE; ITALY; LITHUANIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; RUSSIAN FEDERATION; SMOKING; STATISTICAL ANALYSIS; STROKE; WORLD HEALTH ORGANIZATION;

EID: 0030745248     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.7.1367     Document Type: Article

References (48)

1. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke. 1990;21:989-992.
2. Malmgren R, Warlow C, Bamford J, Sanderock P. Geographical and secular trends in stroke incidence. Lancet. 1987;2:1196-2000.
3. Alter M, Zhang ZX, Sobel E, Fisher M, Davanipour Z, Friday G. Standardized incidence ratios of stroke: a worldwide review. Neuroepidemiology. 1986;5:148-158.
4. WHO MONICA Project Principal Investigators (prepared by Tunstall-Pedoe H). The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Diseases): a major international collaboration. J Clin Epidemiol. 1988;41:105-114.
5. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, part 2: effects of short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335: 827-838.
6. Garraway WM. The changing pattern of hypertension and the declining incidence of stroke. JAMA. 1987;258:214-217.
7. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease, part 1: effects of prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
8. MacMahon S. The effects of antihypertensive drug treatment on the incidence of stroke and of coronary heart disease. Clin Exp Hypertens A. 1989;11:807-823.
9. Vartiainen E, Sarti C, Tuomilehto J, Kuulasmaa K. Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland? BMJ. 1995;310:901-904.
10. McGovern PG, Burke GL, Sprafka JM, Xue S, Folsom AR, Blackburn H. Trends in mortality, morbidity and risk factor levels for stroke from 1960 through 1990. JAMA. 1992;268:753-759.
11. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298:789-794.
12. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269:232-236.
13. Qizilbash N, Duffy SW, Warlow C, Mann J. Lipids are risk factors for ischaemic stroke: overview and review. Cerebrovasc Dis. 1992; 2:127-136.
14. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet. 1995;346:1647-1653.
15. Konishi M, Iso H, Komachi Y, Iida M, Shimamoto T, Jacobs DR, Terao A, Baba S, Sankai T, Ito M. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries: the Akita Pathology Study. Stroke. 1993;24: 954-964.
16. Benfante R, Yano K, Hwang LJ, Curb D, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: implications of shared risk. Stroke. 1994;25:814-820.
17. Lindenstrøm E, Boysen G, Nyboe J, Appleyard M. Stroke incidence in Copenhagen, 1976-1988. Stroke. 1992;23:28-32.
18. Iso H, Jacobs D, Wentworth D, Neaton J, Cohen J. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989;320:904-910.
19. Hebert PR, Gaziano JM, Hennekens CH. An overview of trials of cholesterol lowering and risk of stroke. Arch Intern Med. 1995;155: 50-55.
20. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
21. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001-1009.
22. Asplund K, Tuomilehto J, Stegmayr B, Wester PO, Tunstall Pedoe H. Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med Scand Suppl. 1988;728:26-39.
23. WHO MONICA Project. MONICA Manual, revised edition. Cardiovascular Diseases Unit. Geneva, Switzerland: WHO; 1990.
24. Stegmayr B, Asplund K. Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology. 1992:11:204-213.
25. Asplund K, Bonita R, Kuulasmaa K, Rajakangas A-M, Feigin V, Schaedlich H, Suzuki K, Thorvaldsen P, Tuomilehto J, for the WHO MONICA Project. Multinational comparisons of stroke epidemiology: evaluation of case ascertainment in the WHO MONICA Stroke Study. Stroke. 1995;26:355-360.
26. Wright BM, Dore CF. A random-zero sphygmomanometer. Lancet. 1970;1:337-338.
27. Hense H-W, Koivisto A-M, Kuulasmaa K, Zaborskis A, Kupsc W, Tuomilehto J, for the WHO MONICA Project. Assessment of blood pressure measurement quality in the baseline surveys of the WHO MONICA Project. J Hum Hypertens. 1995;9:935-946.
28. Waterhouse J, Muir C, Correo P, Powell J. Cancer Incidence in Five Continents. International Agency for Research on Cancer, 1976. Lyon: 1976:vol II; IARC Scientific Publication No. 15.
29. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford, England: Blackwell Scientific Publications; 1987.
30. Norusis MJ. SPSS for Windows. Chicago, Il: SPSS Inc; 1993.
31. Bonita R, Beaglehole R, Asplund K. The worldwide problem of stroke. Curr Opin Neurol. 1994;7:5-10.
32. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialised countries since 1950. World Health Stat Q. 1988;38: 155-168.
33. Thom TJ. Stroke mortality trends: an international perspective Ann Epidemiol. 1993;3:509-518.
34. Stewart AW, Kuulasmaa K, Beaglehole R, for the WHO MONICA Project. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int J Epidemiol. 1994;23:505-516.
35. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas A-M, Schroll M, for the WHO MONICA Project. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. Stroke. 1995;26: 361-367.
36. Stegmayr B, Harmsen P, Rajakangas A-M, Rastenyté D, Sarti C, Thorvaldsen P, Tuomilehto J. Stroke around the Baltic Sea: incidence, case fatality and population risk factors in Denmark, Finland, Lithuania and Sweden. Cerebrovasc Dis. 1996;6:80-88.
37. Rosén M, Nyström L, Wall S. Guidelines for regional mortality analysis: an epidemiological approach to health planning. Int J Epidemiol. 1985;14:293-299.
38. Hense HW, Kuulasmaa K, Zaborskis A, Kupsc W, Tuomilehto J, for the WHO MONICA Project. Quality assessment of blood pressure measurements in epidemiologic surveys: the impact of last digit preference and proportions of identical duplicate measurements. Rev Epidémiol Santé Publ. 1990;38-463-468.
39. Keil U, Kuulasmaa K, for the WHO MONICA Project. Risk factors and medical care. Int J Epidemiol. 1989;18(suppl):S46-S55.
40. Dobson A, Filipaik B, Kuulasmaa K, Beaglehole R, Stewart A, Hobbs M, Parsons R, Keil U, Greiser E, Korhonen H, Tuomilehto J. Relations of changes in coronary disease rates and changes in risk factor levels: methodological issues and a practical example. Am J Epidemiol. 1996;143:1025-1034.
41. Lindenstrøm E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ. 1994;309:11-15.
42. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke: a population perspective. Diabetologia. 1995;38:1061-1068.
43. Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol. 1988;128:116-123.
44. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke. Stroke. 1996;27:210-215.
45. Bonita R, Beaglehole R. Increased treatment of hypertension does not explain the decline in stroke mortality in United States, 1970-1980. Hypertension. 1989;13:169-173.
46. Tuomilehto J, Bonita R, Stewart A, Nissinen A, Salonen J. Hypertension, cigarette smoking, and the decline in stroke incidence in eastern Finland. Stroke. 1991;22:7-11.
47. Eisenblätter D, Heinemann L, Claßen E. Community-based stroke incidence trends from the 1970s through the 1980s in East Germany. Stroke. 1995;26:919-923.
48. Heinemann L, Barth W, Hoffmeister H. Trend of cardiovascular risk factors in the East German population 1968-1992. J Clin Epidemiol. 1995;48:787-795.